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INCREASING PNEUMOCOCCAL POLYSACCHARIDE VACCINATION RATES IN 
ADULTS AGE 65 YEARS AND OLDER IN A PRIMARY CARE CLINIC 
 
 




 The purpose of this study was to increase PPSV23 vaccination rates in adults over 
the age of 65 years in a Midwestern primary care clinic.  
For this project, staff was educated regarding interventions including patient 
awareness, provider recommendation, staff and provider education, vaccine access, use of 
the immunization information systems (IIS) and appropriate use of electronic health 
record (EHR) reminders that have been shown to increase vaccination rates.  
Prior to the intervention, data was retrieved, and it was found that between April 
1st-May 31st 2020, there were 162 patients over the age of 65 that presented to the clinic. 
Of those 112 were already vaccinated or received the PPSV23 vaccination, indicating 
that the clinic had a 69% vaccination rate at baseline. After the project intervention and 
during the 8-week study period of April 1st-May 31st 2021 there were 190 patients over 
the age of 65 seen and 151 of those patients were either already vaccinated or received 
the PPSV23 vaccination.  This increased the rate of vaccination to 79%.  Those who 
continued to refuse the vaccination were given a questionnaire to asking for potential 
reasons. 
Vaccination rates increased in the studied primary care clinic from 69% to 
79%.This shows these intervention techniques are successful at increasing vaccination 
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Pneumococcal vaccination is an important preventive health measure that can 
help reduce the rate of pneumococcal infections. According to the Centers for Disease 
Control and Prevention (CDC) (2019a), the Healthy People 2020 goal “is to achieve at 
least 90% coverage for pneumococcal polysaccharide vaccine among persons 65 years of 
age and older.” However, this same data suggests that only 64% of persons 65 years of 
age or older had ever received pneumococcal vaccination. Additionally, more than 65% 
of people who have been hospitalized with pneumococcal disease within the last 3–5 
years were not offered the vaccine (CDC, 2019b). Healthy People 2030 goals for 
immunizations, such as the pneumococcal vaccination are currently still under 
developmental status, this means that it is a “high-priority public health issue that has 
evidence-based interventions to address it, but doesn’t yet have reliable baseline data 
(Office of Disease Prevention and Health Promotion, n.d.). 
Opportunities are missed in our health system every day, both inpatient and 
outpatient. Therefore, more effective programs are needed to ensure there is an increase 
in vaccination rates. These missed opportunities show the importance of this study. 
 The CDC recommends all adults receive routine administration of pneumococcal 
polysaccharide vaccine (PPSV23) at age 65 years or older (CDC, 2019c). This is a one-
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time vaccination after age 65. If the patient received one dose prior to age 65, then the 
dose after age 65 should be given at least 5 years from the prior dose (Musher, 2020). 
This is the vaccine of focus for this project. 
Description of the Problem 
 
  Over 11,500 cases and more than 1,900 deaths occurred in adults over the age of 
65 from invasive pneumococcal disease in the United States in 2016 (CDC, 2020a). More 
than half of the cases that occur each year in adults have an indication for pneumococcal 
polysaccharide vaccine (CDC,2019b). These statements prove statistical significance and 
need for improvement of PPSV23 rate. 
 The impacts of the PPSV23 are well documented. Getting vaccinated can protect 
the individual receiving the vaccination. If the majority of a community gets vaccinated, 
that community can develop herd immunity which decreases the likelihood that the 
community will get the disease. This would cause a decreased chance of an outbreak 
because it is more difficult for the disease to spread. The PPSV23 vaccination is known 
to be 60%–70% effective in preventing disease caused by serotypes included in the 
vaccine (CDC, 2019b). Therefore, getting the vaccination decreases the likelihood of 
contracting illness caused by pneumococcal disease. 
 Pneumococcal disease causes many different illnesses that are preventable by 
vaccination. These include diseases such as pneumonia, bacteremia, meningitis, and otitis 
media. The solution to decreasing the prevalence of these diseases would be increasing 





Significance to Nursing and Patients 
  Improving vaccination rates is significant in improving the health of the older 
population. A nurse's role is to improve the health outcomes of all populations; therefore, 
vaccine compliance is significant to nursing. Education, surveillance, and understanding 
could all help improve vaccination rates. 
Medical staff and provider education regarding vaccines is a factor that limits 
vaccination rate improvement. Adult vaccination remains a low priority for both 
physicians and patients (Doherty et al., 2018). As adults, employers rarely require proof 
of vaccination. Also, many patients are unaware of the recommended immunizations, and 
health care providers do not have time to assess vaccination at every appointment. 
According to Ventola (2016) approximately “65% of people were aware of the 
pneumococcal vaccine, 56% had not gotten it because their doctor had not recommended 
it.” 
 Surveillance is necessary in order to set goals, establish priorities and be able to 
monitor the effectiveness of the program for future adjustments (Doherty et al., 2018). 
Immunization records are often incomplete for adults. Lack of accurate vaccination 
records may also cause missed opportunities to educate and vaccinate patients (Ventola, 
2016).  
 Safety, value, and efficacy of vaccination should be understood by both those 
vaccinating and those receiving the vaccination (Ventola, 2016). This can also be closely 
related to education because at the time of recommending the vaccination the provider 
should be able to educate the patient regarding these attributes. An increase in education 




 The purpose of this project is to increase pneumococcal vaccination rates in the 
adult population age 65 years and older in a Midwestern primary care clinic. The project 
will be implemented using provider/staff education to increase assessment of patient 
vaccination status every appointment/every visit, utilizing appropriate electronic health 
record (EHR) reminders and providing education regarding the PPSV23 vaccination. 
After this implementation if a patient still continues to refuse vaccination, there will be a 
survey questioning the patient as to why the vaccination was refused. The goal is to 
determine if there will be an increase in PPSV23 vaccination rates compared with current 
office strategies among adults age 65 and older in a primary care clinic. 
Theoretical Framework 
This project was grounded using a model called the P3 model that was developed 
with preventative health in mind. In an article by Bednarczyk et al. (2018) the authors 
discuss the development of this model in comparison with other theoretical frameworks. 
The model is able to address the practice-level, provider-level, and patient-level 
components that are often involved in preventive care such as vaccine rate improvement. 
The P3 model was made by gathering key components of other conceptual models, 
“including the Health Belief Model, Theory of Planned Behavior/Theory of Reasoned 
Action, Social Cognitive Theory, Social Ecological Model, and the Systems Model of 
Clinical Preventive Care” (Bednarczyk et al, 2018, p.131). Since this model was formed 
with preventative care in mind it assumes that prevention is the goal. Bednarczyk,et al 
(2018) states that the “P3 Model allows for inclusion of factors at levels that may not be 
addressed fully through standard health promotion and behavioral models” (p.136). An 
 
 5 
example of this would be if a provider does not follow the standard best practice 
guidelines. 
This framework is a great blueprint for the project because it encompasses most 
of the issues that may be a cause of low vaccination rates.  At the practice level, there are 
ways for improvement for example, such as correct utilization of standing orders or if the 
clinic has an available supply of vaccinations. The provider level is able to determine if 
there is vaccine hesitancy due to lack of education or if a provider just is not correctly 
utilizing the electronic health record (EHR) prompts. Finally, it looks at the patient level 
and is able to determine reasons why the patient may be the reason for not vaccinating, 
such as fear of needles, unknown vaccine schedule or fear of costs. 
Figure 1 Graphical Representation of the P3 Model 
 
 6 
Note. This representation of the P3 model shows identification of impacting factors and 
the levels they act within the model (adapted from Bednarczyk et al 2018). 
Needs Assessment Tool 
The strength, weakness, opportunities and threat analysis tool is also known by 
the acronym SWOT. Using a SWOT analysis to examine a project enables the 
examination of the project’s positives and negatives. This analysis tool acts as an 
additional framework to help assist and find ways to eliminate or improve on the project 
weaknesses and to discover opportunities that are available for improvement. If these 
aspects of a project are known, a person is “more likely be able to plan and act 
effectively” (Center for Community Health and Development, n.d.).  
  This particular tool was chosen in addition to the P3 model because in order to 
improve vaccination rates an assessment of needs must be completed to understand the 
strengths and weakness of the current practice. This tool helps examine ways that may 
help improve vaccination rates or find barriers that may cause issues for vaccination rate 
improvement. This can be done at the clinic level, the provider level or the patient level 
as previously discussed with the P3 model. There are many factors that affect why a 
patient chooses to get a particular vaccination or not and in order to improve vaccination 
rates those factors need to be considered. 
Analysis Results 
The SWOT analysis (Table 1) indicates many items under each identified 
category. This list is not inclusive and during project development there is anticipation 
that other items will arise in all categories. Internal issues, both strengths and weaknesses 
are being defined here as tasks that are controlled within the organization such as clinic 
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factors (hours, location, etc.), provider factors (willingness, education, etc.) and staff 
factors. External factors are both opportunities and threats, which are out of the 
organization control, such as patients, insurance, and national guidelines.   
  For internal strengths, the biggest and most important is probably related to the 
amount of evidence supporting the vaccination effectiveness and decrease in disease 
following vaccination. The clinic where the project will be completed has good access to 
care. There are nurse visit slots that enable patients who have been seen within a year to 
schedule appointments for vaccination. There are multiple providers at the clinic who are 
available from 7am-5pm. These providers all have several same-day appointment slots. 
These are appointments slots that are unable to be booked until the same day. The EHR at 
this facility is Epic, which does allow for patient and provider reminder of vaccinations 
that are due. The clinic always stocks the PPSV23 vaccination and has not had any issues 
keeping it in stock. The staff and the providers at this clinic are aware of a needed change 
and improvement and are willing to implement new protocols. Several people within the 
facility have access to the State of Missouri immunization information system website to 
obtain historical vaccines to update immunization records if the patient is unsure of the 
date the vaccination was received or where they received it at.  
  For internal weakness there were also many identified issues that could be 
improved at a clinic level. Although the EHR has the capability for reminders it is not 
being utilized. The utilization of the nurse schedule for vaccines is not being utilized as 
there are currently no standing orders available for vaccination administration. The final 
issue identified was time restraints of providers and staff members required to further 
assess each patient visit for immunization status and provide education regarding the 
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vaccination if needed. 
  External opportunities were found. The most important is that increasing the rate 
of vaccination will lead to a decrease in the amount of pneumococcal illness. Decreased 
hospital visits were another important factor for community opportunity. Ultimately, 
improved vaccination will save the healthcare system financially. 
External threats to PPSV23 rate improvement include anything that risks a 
vaccination not being administered. This includes those who refuse to receive the 
vaccination. These reasons can vary, such as religion, fear of needles, fear of cost, and 
fear of adverse reaction. Other reasons may include the patient being unaware of the 
vaccination schedule, if they are due for the vaccine, or the vaccine is effectiveness.  
Many patients and providers fear cost associated with vaccinations, so another external 
factor is insurance coverage for the vaccine. Lastly, the pneumococcal vaccination 
administration guidelines were updated in November 2019 which increased confusion of 
the new dosing schedule (CDC, 2019c).  
  Considering both positive and negative factors that affect immunization rate 
improvement, there seemed to be enough evidence to support the need for modification 
and improvement of the current process. Results of these factors are displayed in the 
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• What are the barriers to receiving the pneumococcal vaccination among adults 
aged 65 years and older?  
• Will staff/provider education regarding appropriate EHR reminders, assessing 
vaccination status every patient/every time and the use of standing orders improve 
vaccination rates?  
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• Will asking the patient, providing patient education and provider recommendation 
improve vaccination rates? 
• Will the clinic see an increase in vaccination among adults after project 
implementation? 
Definition of Key Terms 
  The following terms will be seen by the reader throughout this paper. For better 
understanding, the definitions are provided here.  
Healthy People 2020 – “Healthy People is a set of goals and objectives with 10-year 
targets designed to guide national health promotion and disease prevention efforts to 
improve the health of all people in the United States” (Department of Health and Senior 
Services, 2010) 
Herd immunity- Also called community immunity, this is is “A situation in which a 
sufficient proportion of a population is immune to an infectious disease (through 
vaccination and/or prior illness) to make its spread from person to person unlikely”(CDC, 
2020b). 
Immunization- “The process of being made immune or resistant to an infectious disease, 
typically by the administration of a vaccine. It implies that you have had an immune 
response” (CDC, 2020b) 
Meningitis- “Inflammation of the brain and spinal cord that can result in permanent brain 
damage and death” (CDC, 2020b) 
Otitis Media- “A viral or bacterial infection that leads to inflammation of the middle ear” 
(CDC, 2020b).  
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Pneumonia- “Inflammation of the lungs characterized by fever, chills, muscle stiffness, 
chest pain, cough, shortness of breath, rapid heart rate and difficulty breathing” (CDC, 
2020b). 
Polysaccharide vaccines- “Vaccines that are composed of long chains of sugar 
molecules that resemble the surface of certain types of bacteria. Polysaccharide vaccines 
are available for pneumococcal disease” (CDC, 2020b). 
Provider- Medical care professional with specialized training that individual that is able 
to assess, diagnose, and treats individuals with medical conditions; physicians, 
physician’s assistant, or nurse practitioner 
Vaccination- “The physical act of administering any vaccine or toxoid” (CDC,2020b). 
Logic Model 
 A logic model (Figure 2) was created to visualize the project. The logic model 
identifies the inputs and outputs utilized to create an intervention. It also identified the 
short-term, medium-term, and long-term goals of the scholarly project. Lastly, it denotes 
assumptions of the author, as well as external factors that could influence the project.  
This model depicts the identification of pneumococcal vaccination inputs that will be 
used to support the project, resources/activities to overcome barriers, and expected 
outcomes of provider/staff education regarding vaccine administration. The model also 
lists outcomes. The outcomes section of this model has been divided into time frames, 






Figure 2  
Logic model for increasing pneumococcal vaccination rates 
 
Summary 
The recommended use of the PPSV23 vaccination can prevent the risk of 
pneumococcal-related diseases and decrease the risk of mortality. Primary care clinics 
have the capability of providing this immunization for all adults age 65 and older. Health 
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care providers must strive to find effective strategies to increase recommended 
vaccination rates and prevent illness. The goal of this project will provide insight on how 
an improved process can increase PPSV23 vaccination rate and bridge the gap towards 

















 In the United States, pneumococcal illness causes many different types of disease. 
Pneumococcal disease is more than just pneumonia and can include acute bacterial 
diseases such as pneumonia, meningitis, bacteremia, sinusitis, and otitis media.  These 
diseases are predominately an issue for those age 65 and older or those with chronic 
medical conditions.  
Impact 
  In order to explain the importance of the vaccine, it is important to look at several 
of those illnesses and their impact to determine how the vaccine can decrease illness 
rates. However, the elderly population or age 65 and older is considered a vulnerable 
population. This age group has an increased risk of pneumococcal disease and will be the 
population of focus for this scholarly project. 
Pneumococcal Pneumonia 
 According to the CDC (2019b), approximately 400,000 hospitalizations from 
pneumococcal pneumonia are estimated to occur annually in the United States.  This type 
of pneumonia has a case-fatality rate of 5-7% and has proven to be much higher in the 
elderly population. So, the use of the PPSV23 vaccination has the potential to decrease 




 About 25-30% of patients with pneumococcal pneumonia also experience 
pneumococcal bacteremia, where a person develops bacteria in the bloodstream. There 
are more than 12,000 cases of this occurring yearly in the United States. The fatality rate 
is up to 60% in the elderly population (CDC, 2019b). This again, can be decreased with 
vaccination. 
Meningitis 
 Pneumococcal bacteria is the cause for over 50% of all cases of meningitis in the 
United States.  The case-fatality rate of pneumococcal meningitis is about 22% among 
adults (CDC, 2019b). The incidence of meningitis has decreased since the introduction of 
the pneumococcal vaccine and could be further decreased with vaccination rate 
improvement. 
Otitis Media 
 Other causes of pneumococcal illness are also present. Another illness occurs in 
the form of otitis media (ear infection). Pneumococci is detected in 28%–55% of ear 
infections (CDC, 2019b). Decreasing the number of ear infections could save a lot of 
unnecessary visits to primary care and urgent cares for antibiotics. 
 Decreasing each of the above listed illnesses could save healthcare dollars. 
Additionally, increasing vaccination rates can decrease illness at both the state and 
national levels. This can be achieved by the improvement of an adult vaccination 






As stated in the introductory chapter, low rates of pneumococcal vaccinations are 
an issue in the United States. Per the Centers for Disease Control (CDC), opportunities to 
vaccinate are missed both inpatient and during outpatient visits to healthcare offices 
(2019b). Effective programs for vaccine delivery are needed. Since the development of 
the pneumococcal vaccines, pneumococcal disease has shown a decline. According to 
trends pneumococcal disease caused by the serotypes covered by PPSV23 declined from 
51 cases per 100,000 people in 1998 to 13 cases per 100,000 people in 2015 in adults 65 
or older (CDC, 2017). This improvement proves the efficacy of vaccination and further 
proves the need for increased vaccination efforts in hopes of disease eradication. The 
CDC also discusses immunization strategies for improved vaccination rates. However, a 
more thorough literature review needs to be done to gain current evidence-based research 
regarding increasing vaccination rates in the adult population.  
Literature Review 
   The attempt to determine a reason behind the low pneumococcal polysaccharide 
vaccination rates in adults above age 65 requires a review of the literature. This review is 
used to examine similarities, differences, and patterns of behaviors among providers and 
patients and obtain the most recent information on vaccinations, knowledge and 
administration. This literature review was conducted using the online databases CINAHL 
and PubMed. The CDC website was an online database that was also utilized for 
vaccination knowledge because the CDC website is a primary resource for best practice 
guidelines regarding vaccination. The focus of the literature review was broad in terms of 
all vaccination types for adults to find why all vaccination uptake is low and was not 
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specific to the pneumococcal vaccines because there was a lack of available literature 
found specific to pneumococcal vaccinations. 
The initial keywords searched, and search phrases, were: “adult pneumococcal 
polysaccharide vaccination rate improvement”, “vaccination rate improvement”, “adult 
pneumococcal vaccination barriers”, “improving vaccine uptake” and “interventions to 
improve adult vaccination rates.”  Results were further narrowed down to include only 
articles in English, those available in full text and articles included were all free and 
available without payment. Upon completion of database search, 13 articles were chosen 
within the criteria based on a review of the article abstract.  
  The review of the literature resulted in many common themes for low vaccination 
rates in the adult populations. The common barriers will be discussed along with ways to 
decrease barriers and increase vaccination uptake. According to multiple studies, vaccine 
coverage for recommended vaccines is low among adults (Barker et al., 2016; Bock et al., 
2016; Bridges et al., 2015; Clark et al., 2018; Ho et al., 2017). Each study identified 
barriers to vaccination. Many of the studies sought to identify a more effective approach 
to improve vaccination rates. The barriers identified were lack of provider 
recommendation, lack of awareness that the vaccination exists, lack of knowledge 
regarding schedule, safety or efficacy, vaccination access, cost, and provider concerns.  
Provider Recommendation 
 Studies have shown that recommendations from a patient’s health care provider 
have a significant impact on immunization rates, yet many patients report they do not 
receive these recommendations from their clinicians (Bock et al., 2016; Bridges et al., 
2016; Clark et al., 2018; Sandler et al., 2016; Zimmerman et al., 2017). According to 
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Sandler et al. (2016) who studied vaccination rates in patients with Rheumatoid arthritis, 
only 3 out of 4 patients said that their providers discussing their risk of infection and only 
2 out of 3 said their providers discussed vaccinations. Another study indicated that 88% 
of people said that would be more likely to receive a vaccination if it included a strong 
recommendation from their physician (Bridges et al., 2016).  
 The CDC (2019a) also supports this. They state that a provider recommendation 
“remains the number one reason parents decide to vaccinate” and even patients who are 
initially reluctant are likely to get a vaccination when provider has a positive attitude 
toward the vaccination (CDC, 2019a). This same source also discusses that providers 
offering vaccinations should use a presumptive approach and assume that the patients 
being seen will choose to vaccinate (CDC, 2019a).  
These statistics show the importance of provider recommendation for patients. 
However, there were also many barriers to providers recommending vaccination that 
were also identified in the literature. 
Provider/Staff Education 
 Provider and staff education seemed to be the most common theme identified. 
Most of the studies identified provider and staff barriers to vaccination rate improvement. 
Common themes included lack of familiarity regarding the vaccine or the schedule, 
difficulty using EHR reminders and/or order sets, uncertainty about the efficacy and/or 
safety of the vaccine, and uncertainty about insurance coverage and prior vaccination 
history.  
 “Interventions to improve immunization rates have focused on modifying health 
care providers’ behavior to encourage them to promote vaccines for adults” (Clark et al., 
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2018, p.292). In order to achieve this, many of the studies studied the effectiveness of 
providing provider and staff education to increase familiarity regarding the vaccination 
and the schedule (Barker et al., 2016; Chan et al., 2015; Bridges et al., 2016; Sebold et 
al., 2018). This is further supported by the fact that many providers get confused about 
the recommended vaccination schedules (Bridges et al., 2016; Clark et al., 2015). There 
were ways identified to assist these barriers.  
 One of the identified issues for health care providers was time constraints 
(MacDougall et al., 2015). Sander et al. (2016) also noted that physicians have 
insufficient amounts of time to discuss and address preventative care needs that are 
necessary. One of the ways to combat time restraints is through the use of standing 
orders. Bridges et al. (2016) found that system interventions such as the use of standing 
orders and use of EHR reminders for vaccines that were due were strategies that 
enhanced health care providers’ success with increasing vaccination rates. Several other 
studies also discussed the utilization of standing orders to remove some burden from the 
physicians (Bock et al., 2016; Sandler et al., 2016).  
 In addition to standing orders and reminders, Clark et al. (2015) offered additional 
recommendations for the use of clinical decision support tools that further aid in 
screening and reminders to ensure administration of vaccines on encounters with patients. 
Another tool discussed was the use of best practice advisory (BPA) tools (McAdam-Marx 
et al., 2016). A BPA is a pop-up reminder in the EHR that serves as an intervention that 
is triggered based on patient demographics to let you know when something is overdue 
such as vaccines (McAdam-Marx et al., 2016).  The last tool identified to aid providers in 
increasing vaccination rates is the use of audit and feedback. The use of this tool was 
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discussed in Clark et al. (2018) and Clark et al. (2015). Audit and feedback measured the 
performance of the provider compared with a set standard. The results are then shared, 
and those results are meant to motivate to meet the defined targeted goals. The 
anticipation is that the provider will modify practice if they know their performance does 
not meet the standard (Clark et al., 2018).  
 Education of providers is important. Providers should be prepared and able to 
answer questions using common terms that patients are able to understand. Vaccine risks 
and benefits are important for providers to be aware of to aid in responding to 
misinformation and concerns that patients may have. Providers can also train staff to 
discuss these basic vaccine questions to help save time during visits and ensure patients 
are hearing consistent messages about vaccines (CDC, 2019a). Consistency often helps 
relay a positive message and helps the patient have a better understanding which 
increases the likelihood they will receive the vaccination. 
  Each of these different tools can help assist the provider to identify patients who 
are due for the needed vaccination. This can then be used to appropriately assess 
vaccination status. Then, ultimately recommend vaccination when needed to raise 
awareness. 
Lack of Awareness 
According to Bock et al. (2016), 84% of the people surveyed are unaware that a 
pneumococcal vaccination even exists for adults. In this study this lack of awareness was 
identified as the main barrier to not receiving a vaccination. This was also discussed as a 
leading factor impacting vaccination status in the study by Bridges et al. (2016). Also, in 
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a study by Ho et al. (2016), many of the participants were familiar with influenza 
vaccinations but many had never heard of pneumococcal vaccination. 
  Lack of education regarding safety, efficacy and vaccine schedule are other 
reasons patients do not receive vaccinations. Zimmerman et al. (2017) discusses these 
patient-related barriers to include not knowing that a vaccine was recommended, not 
believing that the clinician recommended the vaccine, and fear of vaccine side effects. 
According to Bridges et al. (2016), one of the main reasons for not getting vaccinated 
was “the belief that the vaccine was not needed because they were healthy” (p.117). This 
was also an identified theme in a study by MacDougall et al. (2016) where participants 
thought that all relevant vaccines were administered in childhood. Eighty-three percent of 
people in this same study said that they would be more likely to receive a vaccination if 
they had more knowledge about the vaccine effectiveness (Bridges et al., 2016). Ho et al. 
(2016) discussed that the main barriers identified by research were “poor knowledge of 
vaccinations and fear of side effects.” This lack of education leads to decreased 
vaccination rates. 
Access to Vaccines 
 Access to care and vaccinations was another reason that many patients state they 
are unable to be adequately vaccinated. Bridges et al. (2016) discusses that pharmacies, 
workplaces and other retail settings are becoming important places for adults to receive 
vaccinations. They offer access and convenience for patients that many healthcare 
settings do not. Other studies also discussed the importance of expanding access to sites 
where patients can be vaccinated (Clark et al., 2015; MacDougall et al., 2015). Bridges et 
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al. (2016), states that 30% of adults getting vaccinated in a retail/pharmacy setting do so 
during times when healthcare offices are typically closed, such as on weekends or in the 
evenings. Another gap that was identified was that there is often difficulty accessing a 
consistent primary care provider, so this forces patients to seek care at a variety of 
locations where they receive vaccines at multiple places without proper communication 
between facilities (MacDougall et al., 2015).  
  The CDC also identified access barriers. Clinic hours were again discussed for 
those patients who are working long hours and are unable to make it into a clinic, and 
long wait times at clinics waiting to see a provider and transportation issues were all 
identified (CDC, 2019a). Overcoming these barriers such as extending clinic hours, 
staggering schedules, and holding vaccination clinics were all ways listed to overcome 
these obstacles (CDC, 2019a). These obstacles regarding access increase the need for 
better communication amongst healthcare organizations in order to improve vaccine 
coverage. 
Immunization Information Systems (IIS) 
 Electronic health records can help increase vaccination rates. It was discussed 
under the provider recommendation section in terms of reminders and order sets/standing 
orders. Another way to use technology to assist in increased vaccination rates is through 
the use of immunization information systems (IIS). IIS are computer-based databases that 
record vaccination doses that are given by participating healthcare professionals/ entities 
who live in a certain area (Groom et al., 2015).  A study by Groom et al. (2015) looked at 
the IIS function in order to create ways to increase vaccination rates, determine vaccine 
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status, and provide missed vaccine opportunities. Other studies also briefly mention that 
IISs could also contribute to improving adult vaccination rates (Bridges et al., 2016).  
According to the CDC (2019a), the use of IIS is important at both the level of clinical 
care and at the population level. IIS can provide a one stop shop for immunization 
histories on a patient that a clinician is able to use to see if a vaccine is due at the time of 
service (CDC, 2019). The use of IIS can also provide aggregate information for use in 
disease surveillance and for helping direct public health officials with goals to increase 
vaccine use and decrease the rates of vaccine preventable disease (CDC, 2019a) 
 IISs can be retrieved in clinical settings and offices to see which vaccines the 
patient is due for. This system allows for a more up to date/complete vaccination record. 
IIS also eliminate the need of having to rely on patient memory or recall. 
Cost 
The last theme identified throughout the literature seems to be one that was least 
discussed: cost. This may be due to providers and patients having little to no control over 
cost. It basically comes down to organizations and insurance coverage. Regardless, cost 
was identified as a common theme for vaccination hesitancy. Bock et al. (2016) found 
that almost 5% of people surveyed said that they were not vaccinated due to cost. Bridges 
et al. (2015) further explains that there are many factors to consider in terms of cost, 
including “how adult vaccinations are paid for by private and public insurers, limited 
funding for vaccination of uninsured adults, costs of and requirements for stocking 
vaccines, concerns among providers about adequate reimbursement for vaccination.” 
Vaccination rates are shown to be lower in adults who do not have health insurance 
(Bridges et al., 2015). Reducing out-of-pocket expenses is one way that was identified to 
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increase vaccination rates (Clark et al., 2015). Some people even believe that 
vaccinations for the elderly should be provided free of charge (Ho et al., 2017). 
Not only do patients have cost concerns, but so do organizations. MacDougall et 
al. (2015) discussed the cost of purchasing and stocking vaccinations at the clinic level. 
This coupled with the unknown reimbursement rates of most insurance companies seems 
to provide fear that decreases providers willingness to offer the vaccine. Decreasing costs 
of vaccinations or having vaccination programs that offer lower costs could increase 
vaccination rates by allowing patients affordability and by increasing provider 
willingness to recommend. 
Practice Change Recommendations 
Increasing vaccination rates will require several different interventions. It was 
identified that providers and staff need to assess the vaccination status of patients at every 
clinical encounter. Second, using available reminder tools in the EHR (both sick and well 
visits can increase vaccination rates). Third, providers need to strongly recommend 
vaccines that are needed, and vaccinations need to be offered at the same visit those 
vaccinations are recommended.  If vaccines are not available, the patient should be 
offered a referral for the vaccination. Finally, the vaccinations need to be documented 
(which includes the use of IIS). 
Summary 
Many common themes were identified for barriers to receiving vaccinations. 
These barriers were provider recommendation to receive the vaccination, staff and 
provider education regarding the vaccination in terms of schedule, efficacy and side 
effects, lack of awareness about the availability of the vaccine, access to the vaccine, the 
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use of the IIS and appropriate use of EHR reminders and cost. Each of these individual 
factors work together to ultimately increase vaccination rates. 
Provider recommendation was identified as a primary reason a patient chooses to 
vaccinate or not. Providers and staff should assess vaccination status of every patient at 
every appointment. They should also be educated to provide an evidence-based 
recommendation for the patient’s timing in receiving the vaccination. In addition, they 
should be available to answer questions the patient may have regarding the vaccine. This 
will help ensure the patient has awareness that a vaccine exists. The use of the EHR 
should be utilized for reminders and apply IIS to obtain complete vaccination histories on 
patients. Lastly, providers and healthcare organizations need to ensure clinic hours are 
adapted or that schedules are staggered to help patients obtain access to care. 
These barriers are important to understand in order to create ways to overcome 
them. The use of the practice change recommendations will improve vaccination rate 






















 The project design and target population were selected after analysis of the CDC’s 
and ACIP’s recommendations of the pneumococcal polysaccharide (PPSV23) 
vaccination for adults, as well as a review of literature of vaccinating this age group.  The 
target population for this study was chosen because the ages 65 and older is believed to 
have the greatest risk for contracting and having issues from the diseases for which the 
vaccination protects against. Pneumococcal disease is proven to be associated with 
pneumonia, meningitis, otitis media and bacteremia as discussed in the previous chapters. 
The focus of this project was to provide education to increase the vaccination rate of 
PPSV23 in adults age 65 years and older in a primary care clinic in the Midwest. 
Immunizations were offered on-site by the clinic where the study was performed. This 
chapter will discuss the methodology implemented to perform this study. 
Project Design 
The project followed a quasi-experimental design evaluating the rate of 
pneumococcal vaccination before and after the educational intervention with the clinic 
staff. The education intervention was provided to each person employed at the clinic who 
comes in contact with patients on a regular basis. The front desk staff was educated 
regarding the importance of providing handouts to all patients who were overdue for any 
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and all health maintenance topics which included the pneumococcal vaccination.  The 
pneumococcal vaccination, if over-due was highlighted to draw specific attention for the 
purpose of the project. This allowed the patients to review the paperwork after check-in, 
make corrections and review the information with the nurse upon rooming.  The nurse, 
while rooming assessed pneumococcal vaccination status for every patient at every 
encounter and if applicable obtained documentation of past immunizations from another 
provider, pharmacy, or the state immunization information system (IIS). If the patient 
required a pneumococcal vaccination and agreed, the nurse used standing orders to 
administer the vaccination. When administering the pneumococcal vaccination, the nurse 
also provided the patient with a vaccination information sheet (VIS). Finally, the provider 
saw the patient and if vaccination has not already been completed, asked the patient about 
the pneumococcal vaccination by using the EHR reminder/care gaps. The provider then 
educated the patient regarding the pneumococcal vaccination guidelines and 
effectiveness.  At checkout, if the pneumococcal vaccination had still not been ordered, 
the patient was asked to complete anonymous questionnaire about reasons for refusing 
the vaccination. This questionnaire included a variety of reasons why the vaccination was 
not received or refused, such as fear of needles, fear of cost, religious preference, was not 
asked, do not know enough information, etc. 
Data collected was both quantitative and qualitative in nature. The quantitative 
data was retrieved using the clinics EHR, Epic. Quantitative data consisted of baseline 
pneumococcal vaccination status of all adults seen in the clinic in the twelve months prior 
to project implementation and was obtained through a review of the clinic’s EHR and 
was used to compare patient vaccination status for the PPSV23 vaccine before and after 
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project implementation. Data was obtained with the assistance of the clinic manager and 
consisted of only numbers of vaccinations and was free of patient identifiers. Additional 
data retrieved was related to demographics data such as race and gender. This 
information was also free of patient identifiers. Qualitative data about patient’s refusal 
reasons was collected from all patients who refused vaccination during the project time 
frame. 
  Before and after comparison of patient vaccination status was used to determine if 
staff education lead to improved pneumococcal immunization rates. Then, if staff 
education was ineffective, a questionnaire was given to determine what additional 
reasons patients gave for vaccination refusal. This information was gathered to guide 
future projects. 
Action/Procedure 
After gaining approval from SSM Healthcare and Pittsburg State University, 
education was provided to the staff at the SSM Family Practice Clinic in Jefferson City, 
MO.  Education was presented during the next staff meeting following approval.  The 
date staff education was performed was on March 16, 2021. Collected data was divided 
into two categories (i) those who are immunized following the appointment and (ii) those 
who were not.  
Target Population 
 The target population for this study was made up of patients at or above 65 years 






Participants included all patients over the age of 65 years of age who were seen at 
the SSM Edgewood Clinic in Jefferson City, MO during the study period. Information 
about race, ethnicity and gender was collected to assess if a difference exists in the 
demographics of those who agree to the vaccine and those who do not. Patients who 
spoke other languages were included as well. This clinic utilized a computer-based 
translation system so all patients were able to understand the information being 
presented. 
Patients who were not seen during the study period were excluded from the study. 
Additionally, patients younger than 65 years of age were also excluded. Patients were not 
excluded based on race, ethnicity of language as stated above. 
Setting 
The project took place at the SSM Edgewood Family Practice Clinic in Jefferson 
City, MO.  This clinic is a family practice clinic that offers primary care services which 
include, preventative screenings, mental health care, chronic disease management, illness 
visits and well man and well woman visits. The SSM Health organization accepts all 
insurance plan and sees patients regardless of ability to pay.  
Protection of Human Subjects 
An Institutional Review Board (IRB) application was submitted to the Pittsburg 
State University Committee for the Protection of Human Research Subjects (CPHRS) for 
review and approval. Upon review, the study qualified for exempt status. All interactions 
with subjects remained confidential, no personal information was obtained from patients 
participating in the educational intervention, the vaccination data collected did not 
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include any personal identifiers. Moreover, the study did not include vulnerable subjects 
such as children or prisoners.  
Data collection took place after the proper institutional review process was 
completed and final approval was obtained from Pittsburg State University and the Irene 
Ransom Bradley School of Nursing. All quantitative data was collected using the Epic 
EHR and only numbers of vaccinated or unvaccinated patients were obtained and was 
free of any patient identifier. Qualitative data was collected in the form of an 
administered questionnaire. No deception of subjects took place, nor techniques used that 
caused discomfort or harassment. Confidentiality was maintained with the questionnaires; 
no identifying patient information was collected, and completed questionnaires were 
placed securely in a ballot box after visit which was not be opened until after study 
completion for data collection. Consent was implied if the patient chose to complete the 
survey.   
Ethical Considerations 
  An ethical dilemma regarding vaccination rate improvement involves the balance 
of personal autonomy and choice versus protection of both that individual and the entire 
community at risk. A vaccine provides a dual benefit: a direct benefit to the person 
receiving it, and an indirect benefit to other members of the community by offering herd 
immunity. Patients will often look up to healthcare providers when making medical 
decisions, including vaccinations.  Most healthcare providers, favor vaccination and seek 
ways to overcome these patients’ resistance. In turn, providers face the challenge of 
balancing the ethical principles of non-maleficence (do no harm) and beneficence (do 
good) when educating patients regarding vaccine choices. 
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These principles can often be in conflict when addressing vaccine risks. In doing 
good, the provider would have the responsibility to promote vaccines for the benefit of 
the patient and community, despite opposition. However, looking at the principle of non-
maleficence requires the provider to inform patients of the risk of the vaccinations and 
therefore might lead patients to refuse the vaccination the provider is promoting. 
  Ideally, decisions about vaccination should be reached through mutual 
participation in a shared decision-making process which would promote patient 
autonomy and avoid coercion.  
Instruments 
 A cross-sectional questionnaire survey on resistance or refusal to vaccination was 
administered to patients who continued to refuse the PPSV23 vaccination after 
intervention. The survey inquired about lack of education, lack of provider 
recommendation, religious beliefs, and other reasons behind refusing the PPSV23 
vaccine. Implied consent was assumed with completion and return of the survey. This 
tool was implemented to enhance the validity of the study’s results and future attempts at 
educating on PPSV23 vaccination to directly target reservations to vaccinate. 
Procedure 
 
After IRB approval, the educational offering to staff took place on March 16, 
2021 in collaboration with SSM Health. This offering consisted of a discussion at staff 
meeting regarding the importance of the PPSV23 vaccination and how vaccination rates 
can be improved. At the end of the presentation, participants were able to ask questions to 
the researcher if desired.  
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After the educational offering clinic staff immediately started implementing 
discussed behaviors which included providing patients with handout for overdue health 
maintenance at every visit, assessing pneumococcal vaccination status at every 
appointment and obtaining historical vaccination or administering vaccinations if due. 
Patients who continued to refuse were given a post survey asking for reasons for refusal.  
The project will occur during an eight-week time period, through April 1st to May 31st, 
2021. During this time, staff continued implementation strategies to hopefully increase 
vaccination rates and offering surveys to those who refuse. After project completion, data 
was run through Epic which is the EHR system utilized by SSM Health.  This data was 
compared to previously collected data from one year prior to implementation to assess 
improvement. Data was obtained by the help of the clinic manager. Surveys were 
collected from the ballot box, and responses were analyzed for reasons of vaccination 
refusal. Demographic data to include age, gender, and ethnicity were retrieved from the 
EHR to evaluate any difference in the demographics of those who agree to the vaccine 
and those who don’t.  
Budget  
 
  No cost was incurred for the survey or project. The creation and distribution of 
the surveys utilized paper provided by the SSM health clinic. Patients were not offered 
reimbursement for participation. 
Strengths/Limitations 
 A limitation identified is the guideline update to the pneumococcal administration 
guidelines in November of 2019. This guideline update could have caused some 
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confusion to staff and providers.  Some providers and staff do not stay current on 
guidelines.  
Covid19 was also a limiting factor for this study. Initially it was planned that 
there would be another clinic included, however, due to the pandemic, and social 
distancing, educational opportunities were difficult. Additionally, the Covid19 
vaccination was a priority due to the global pandemic, so this vaccination took 
precedence over the pneumococcal vaccination. Current guideline recommended that no 
vaccination should be administered within two weeks pre and post Covid19 vaccination 
series. 
Strengths identified are that vaccinations were available at the clinic and could be 
given the same day that they were offered. Additionally, Covid19 also could be viewed as 
a strength. This was due to many patients may have had an altered opinion regarding 
vaccinations during the pandemic. 
Evaluation plan 
The goal of the data collected was to determine whether or not new procedures 
would increase PPSV23 vaccination rates in adults age 65 years and older in a primary 
care clinic in Jefferson City, MO when comparing rates from the previous year. In 
comparing vaccination rates from the same time frame from the previous year a rise in 
rates would indicate the need for improved clinical process for vaccination education and 
administration. The survey results were an important addition to the data gathered 
because they may indicate how future interventions could be done to help increase 
vaccination rates. Depending on what the analysis shows, education interventions similar 
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to the one implemented in this study could be replicated to further improve rates of this 
vaccination or others. 
Project Sustainability 
If intervention proved effective in increasing PPSV23 vaccination rates among 
older adults, bi-annual attempts toward staff education using the strategies implemented 
in this study would be warranted to use in this clinic and other primary care clinics 
throughout the state of Missouri to improve overall vaccination coverage. Plans to 
execute a universal educational intervention to be used throughout the state would require 
a multidisciplinary approach to ensure sustainability. Collaboration between many clinics 
would be essential for the replication and implementation of the interventions utilized in 
this study. 
Summary 
 Increasing vaccination rates should be focus of all healthcare providers. 
Healthcare providers play a key role to significantly increase vaccination rates through 
the use of screening and education. The goal of this project was to increase PPSV23 
vaccination rates. This chapter discussed in detail the population studied, the procedure 
for study development and data collection. By comparing pneumococcal vaccination 
rates to those in the prior year, we can assess if vaccination rates increased after 
intervention. This knowledge would encourage staff to always assess and ask patients 















Evaluation of Results 
 
 
 The purpose of this study was to increase PPSV23 vaccination rates in adults over 
the age of 65 years in a midwestern primary care clinic. The project also attempted to 
find out why patients continue to refuse the PPSV23 vaccination after the intervention 
strategies were utilized to help aid in future projects. Staff was educated to notify the 
patient that they are overdue for the PPSV23 vaccination by assessing vaccination status 
at every appointment for every patient, obtaining historical vaccinations data from other 
providers, pharmacies or the state IIS, and ultimately administering the vaccination after 
providing education to the patient. Data collection started after staff education was 
provided and rates were compared from one year prior to the educational intervention. 
 This chapter will discuss the population that was studied. It will provide an 
analysis of the data collected as it relates to the purpose of the project. Finally, it will 
discuss the results of the project in detail. 
Sample 
 Once approval was gained from Pittsburg State University IRB and SSM Health, 
employees were offered an educational intervention that consisted of a PowerPoint 
presentation regarding intervention techniques that would be used within the clinic to 
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hopefully increase PPSV23 vaccination rates. This staff education was performed on 
March 16, 2021. Data collection began on April 1, 2021 and ran through May 31, 2021.  
Inclusion criteria were all patients who were scheduled to be seen in the clinic 
during the data collection period who were age 65 or older. Information about race, 
ethnicity and gender was also collected to assess if a difference exists in the 
demographics of those who agree to the vaccine and those who do not.  Patients who 
speak other languages were also included, as the clinic utilizes a computer-based 
translation system so patients were able to understand the information and give consent. 
Patients not seen during the study period were excluded from the study. 
Additionally, those patients younger than 65 years of age were also excluded. 
Data was collected through a report ran through the clinics EHR record, EPIC. 
This allowed for historical data to be retrieved from one year prior to the study before the 
staff education to compare to current data after the education.  
Project Variables 
 The independent variable for this study was the education that was provided to 
staff members of the SSM Family Medicine Clinic in Jefferson City, MO. The education 
emphasized the importance of the PPSV23 vaccination, along with efficacy, side effects, 
vaccination schedule and what data has been shown to help increase vaccination rates.  
 The dependent variable for this study was the clinics vaccination rates prior to and 
after the educational intervention for the staff.  The goal was to see if the dependent 
variables were affected by the provided education. The perceived barriers to vaccinate 
were included in an anonymous survey that was given to the patient after the patient visit 
was complete. The effect on the dependent variable was shown in comparison to the 
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previous year vaccination rates to the rates after the education was done and new 
techniques were initiated. 
Analysis of Project Questions 
 Data was collected to address the aforementioned needs and answer the following 
project questions: 
• What are the barriers to receiving the pneumococcal vaccination among adults 
aged 65 years and older?  
• Will staff/provider education regarding appropriate EHR reminders, assessing 
vaccination status every patient/every time and the use of standing orders improve 
vaccination rates?  
• Will asking the patient, providing patient education and provider recommendation 
improve vaccination rates? 
• Will the clinic see an increase in vaccination among adults after project 
implementation? 
Research Question 1 
Question one was “what are the barriers to receiving the pneumococcal 
vaccination among adults aged 65 years and older?” This question was addressed through 
a review of the literature and it was found that the lack of provider recommendation was 
the foremost barrier to vaccination. Another barrier included lack of provider or staff 
education in terms of vaccination schedules, difficulty using EHR reminders and/or order 
sets, uncertainty about the efficacy and/or safety of the vaccine, and uncertainty about 
insurance coverage and prior vaccination history. Lack of patient awareness, vaccination 
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access, and cost were other identified barriers to receiving vaccinations that were 
addressed.  
This was also further assessed in a post survey for vaccination refusal to see if any 
additional barriers existed. Out of the 39 patients who refused vaccination between the 
study dates, 22 surveys were returned. The survey results showed the majority, 8 out of 
22 people refused based on the Covid19 vaccination. Those wanting to receive or who 
had already received the Covid19 vaccination had to wait two weeks pre-series and two 
weeks post-series before receiving another vaccination.  Five people listed “I don’t want 
to” as a reason. Four people expressed safety concerns primarily related to allergies or 
other medication sensitivities. Other reasons were also listed and are displayed in Table 4 
below.  
Research Question 2 
Question number two was “will staff/provider education regarding appropriate 
EHR reminders, assessing vaccination status every patient/every time and the use of 
standing orders improve vaccination rates?” This was addressed after the project was 
performed. Baseline clinic vaccination rates before implementation of staff and provider 
education was at 69%. Data was historically retrieved from the EHR from one-year prior 
to the education. After the educational training that was done on March 15, 2021, a 
second period of data was ran from April 1-May 30, 2021 which showed the clinic 
vaccination rate after staff and provider education was increased to 79%.  
Research Question 3 
Question number three was, “will asking the patient, providing patient education 
and provider recommendation improve vaccination rates?” which can be answered 
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collectively with question two. Pre-intervention before asking the patient, proving patient 
education and provider recommendation the baseline clinic vaccination rate was at 69%. 
After these intervention techniques, the clinic vaccination rate was at 79%.  
Research Question 4 
  The final research question was “will the clinic see an increase in vaccination 
among adults after project implementation?” This was answered by comparing baseline 
data prior to the project intervention. Baseline data was at 69%. This data was compared 
the data after staff education and new implementation of assessing vaccination status at 
every patient appointment, so they are aware of the vaccination, providing patient 
education and then recommending the patient receive the vaccination.  The after 
invervention PPSV23 vaccination rate ended at 79%.  
Additional Analysis 
 Baseline data was retrieved from the clinic EHR, EPIC. The total of number of 
patients seen over the age of 65 in the SSM Family Medicine clinic during April 1- May 
31, 2020 totaled 161 patients. 112 of these patients had historical vaccinations recorded 
or received vaccinations during this time period which showed the clinic had a 69% 
baseline vaccination rate during this two-month time period. Table 2 below shows the 
total number of patients, those were vaccinated versus unvaccinated and shows 







 Baseline PPSV23 Vaccination Rates April 1-May 30, 2020 
  VACCINATED UNVACCINATED 
TOTAL=162 All patients 
over age 65 
112 50 
GENDER Men 47 27 




White 109 50 
Black 1 0 
Pacific Islander 1 0 








 Staff education was provided using the PowerPoint that is displayed in Appendix 
B. This was performed on March 15, 2021. Project implementation spanned from April 
1-May 31, 2021. Project implementation consisted of giving patients an overdue health 
maintenance handout when the patient checked in for their appointment by the front 
reception staff. This handout stated all screening tests/vaccinations that were overdue 
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(colonoscopy, mammogram, CT lung cancer screening, etc.). The PPSV23 vaccination, if 
due, was highlighted using a yellow highlighter to draw attention to this specific 
vaccination. The patient held onto this sheet of paper while in the waiting room until their 
roomed appointment time. The nurse, while rooming, assessed the status of the PPSV23 
vaccination status at every patient appointment. If the vaccination was overdue, the nurse 
asked the patient if they previously had received this vaccine. If yes, they attempted to 
gain documentation of this historically given vaccination either from the state IIS or from 
a previous provider. If the patient had not previously received the vaccine, they were then 
asked if they would like to have the vaccination on the date they were in the office. If the 
patient required more information the staff provided education regarding the vaccination 
schedule, efficacy, side effects, and purpose of the vaccination. The nurse would then 
administer the vaccination with standing orders. Additionally, when the provider went to 
see the patient after the rooming process, they would also look in the EHR to see if the 
pneumococcal vaccination had been documented and if not use the EHR reminders to 
recommend the vaccination to the patient, find out if they had any additional questions 
and then ultimately ask if they were interested in receiving the vaccine. If the patient 
continued to refuse the vaccine, then at checkout, patients were anonymously asked to 
submit a survey asking about reasons why and submit this survey into a locked ballot 
box. This ballot box sat at check-out desk during the day, was locked into a cabinet 
drawer at night and only the researcher had access to the key to ensure it could not be 
accessed during the project period. Following the project completion date on May 31, 




 The total of number of patients seen over the age of 65 in the SSM Family 
Medicine clinic during April 1- May 31, 2021 totaled 190 patients. 151 of these patients 
had historical vaccinations recorded or received vaccinations during this time period 
which showed the clinic had a 79% vaccination rate during this two-month time period. 
Table 3 shows the total number of patients, those who were vaccinated versus 
unvaccinated, and shows comparisons based on gender, race and ethnicity.  
Table 3 
PPSV23 Vaccination Rates April 1-May 30, 2021 After Implementation 
  VACCINATED UNVACCINATED 
TOTAL=190 All patients 
over age 65 
151 39 
GENDER Men 49 9 




White 146 39 
Black 2 0 












Other Ethnicity 0 0 
 
 Additionally, a compilation of responses from the surveys from those who 
continued to refuse vaccination were analyzed for reasons of vaccination refusal. Refusal 
reasons are compiled in Table 4.  
Table 4 
Pneumococcal Vaccination Survey Results 
Quantity Reason from Survey Patient comments (if any) 
5 Other, please describe “I just don’t want to.” 
1 Fear of needles   
8 Wanting to receive or had 
already received the 
Covid19 vaccination 
 
4 Safety concerns  “have a lot of allergies, 
fear of allergy” 
 
“does not do vaccines 
based on sensitivities to 
other meds.” 
 
“too sensitive to 
everything.” 
 
“do not want anything 
extra like that in my body.” 
2 Prefer not to disclose my 
reasoning 
 
1 Personal belief “do not believe in 
vaccines.” 
1 Multiple boxes checked- 
religious reasons, personal 






This purpose of the present study was to increase PPSV23 vaccination rates in 
adults over the age of 65 years in a midwestern primary care clinic. This was done after 
provider and staff education. Results of the data analysis and comparison revealed 
findings significant to the purpose of the study.  The study outcomes indicate that 
education on staff may have a positive effect on increasing vaccination rates. The clinic 
vaccination rates increased from 69% to 79%, which showed that these interventions 

















The intention of this project was to see if staff education and selected intervention 
would increase pneumococcal polysaccharide vaccination rates in adults over the age of 
65 in a midwestern primary care clinic. The number of patients who were vaccinated with 
the PPSV23 vaccination from April 1-May 31, 2020, were compared to those who were 
vaccinated in the same time frame in 2021 after staff education was performed at the 
clinic being studied. The data collected indicates that staff education in terms of making 
patients aware, assessing vaccination status at every appointment, following provider 
recommendations, and the using of standing orders and appropriate EHR reminder 
utilization does increase PPSV23 vaccination rates in adults over the age of 65 years. 
Relationship of Outcomes to Research 
One of the supporting opening statements that was made to introduce this project 
was that the Healthy People 2020 goal “is to achieve at least 90% coverage for 
pneumococcal polysaccharide vaccine among persons 65 years of age and older” (CDC, 
2019a). However, since the original project was started Healthy People 2030 goals have 
been formed. This goal changed slightly and is now is more generalized and states 
“Reduce the rate of hospital admissions for pneumonia among older adults.” Older adults 
are those age 65 years and older. This guideline is using a baseline of 713.9 hospital 
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admissions for pneumonia per 100,000 adults aged 65 years and over in 2016 and has a 
target of 642.5 admissions per 100,000 adults of the same age.  The evidence-based 
resources related to this objective refers back to the pneumococcal vaccination guidelines 
(Office of Disease Prevention and Health Promotion, n.d.).  
 There are two other Healthy People 2030 objectives that are currently under 
developmental status relating back to this study in terms of vaccinations but are not 
specific to PPSV23 vaccination. These objectives are to “increase the proportion of 
immunization information systems that track adult immunizations across the lifespan” 
and “Increase the proportion of adults age 19 years or older who receive recommended 
age-appropriate vaccines.” However, these two objectives are still under development 
which means that they are being viewed as a high-priority public health issue that has 
evidence-based interventions to address it, but there is no current reliable baseline data 
(Office of Disease Prevention and Health Promotion, n.d.). 
 The data gathered in this project does not correlate with the 2030 goals, but data 
did fall short of the Health People 2020 goal at only raising pneumococcal vaccination 
rates from 69-79%. However, a 10% improvement in vaccination rates did show 
significant improvement after only a two-month study period.  
Observations 
Noteworthy observations made were that vaccination rates were affected by the 
global Covid19 pandemic. This was included on the post-vaccination refusal survey. 
Patients who continued to decline vaccination were asked to provide additional 
information as to why they still preferred not to receive the vaccination. Based on those 
who returned the survey, eight additional patients stated that would have received the 
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vaccination if it was not for the timing of their scheduled Covid19 vaccinations which 
were given priority due to the current pandemic.  If, all eight of those patients would have 
indeed received the pneumococcal vaccination the percentage would have increased to 
84%, which would have increased the 10% improvement rate to 15%.  
Evaluation of Theoretical Framework 
The theoretical framework applied to this project was the P3 model. This 
framework was a good fit for this project and provided a good blueprint for the basis of 
the project because the project was able to follow the practice level, provider level, and 
patient level components discussed in the framework that is seen in Figure 1 displayed in 
Chapter 1. At the practice level, correct utilization of standing orders was addressed in 
the staff education. At the provider level, the providers were educated regarding vaccine 
hesitancy due to lack of education and correct utilization of the EHR prompts. Finally, at 
the patient level, a survey was given to determine reasons why the patient may be the 
reason for not vaccinating, such as fear of needles, unknown vaccine schedule or fear of 
costs. 
Evaluation of Logic Model 
In Chapter 1 (Figure 2), a logic model was provided to show the short-term, 
intermediate, and long-term outcomes of implementing provider and staff education on 
ways to increase PPSV23 vaccination rates. The short-term goal of improvement of 
clinical vaccination rates was met with this project.  The project did not evaluate 
improved clinician education regarding vaccination- although, while providers did 
verbalize this to be true at the project conclusion, there was no official evaluation 
method. The use of Show Me Vax (Missouri IIS) and EHR reminders were utilized 
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throughout the project.  Finally, there was also improvement of clinic vaccination rates. 
The intermediate-goals and long-term goals will need further evaluation to assess on 
future projects. 
Limitations 
 This study was not without bias and limiting factors. The comparative/historical 
data was pulled from April-May 2020. This was right in the middle of the Covid19 
pandemic which could have skewed the total number of patient visits or the visit types 
and this information was not pulled for confidentiality and HIPAA reasons. 
The time allotted for data collection could also be considered a limiting factor. 
After staff education data was only obtained for an eight-week period of time. A longer 
allotment period would have assessed sustainability for intervention.  
The study lacked clinic diversity as it was only performed using one clinic and the 
staff employed within that clinic. This was due to social distancing guidelines and 
attempting to limit staffing based on the Covid19 pandemic. This makes the study 
potentially lack generalizability since there was no additional clinics studied. 
Finally, the study lacked a diverse patient population to determine if there was 
any vaccination bias based on rates or ethnicity. This data was pulled but there were 
really only a few patients who identified as another race or ethnicity. There was lack of 
data to determine if there is a difference across race and/or ethnic groups. 
Implications for Future Projects 
Limitations stated above should be addressed for future studies. Future studies 
should be completed with larger sample sizes, additional clinics and larger geographical 
areas, and obtain a more diverse patient population. Looking at reasons for vaccination 
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refusals and coming up with ways to decrease reasons identified would also be areas for 
additional project expansion.  
 
Implications for Practice 
Vaccinations are some of the best ways to prevent diseases and illnesses.  The 
incidence, prevalence, morbidity and mortality caused by vaccine-preventable diseases 
have all been decreased by their use.  There are many different vaccine-preventable 
diseases however, and due to the significance regarding vaccination against 
pneumococcal disease, there needs to be improvement in vaccination rates against this 
disease. The State of Missouri, where this project was performed, has low PPSV23 rates, 
and there is need for improvement. These low rates are proven to be both a state and a 
healthcare issue, and the need for a health impact assessment may be beneficial for future 
practice. In the State of Missouri, the pneumococcal vaccination rate is at 74.4%, which 
was decreased from 77.7% in 2017 (CDC, 2019d). This gives Missouri plenty of room 
for improvement. There needs to more effective programs to ensure there is an increase 
in adult vaccination rates.  This is where practice change is necessary. 
The impacts of the PPSV23 are well documented.  Getting vaccinated can protect 
the individual receiving the vaccination. If the majority of a community gets vaccinated, 
that community can develop what is called herd immunity, which decreases the 
likelihood that the community will get the disease. This would be a decrease chance of an 
outbreak because it is harder for the disease to spread. To improve pneumococcal 
vaccination rates, it is necessary to identify barriers to increased uptake among the adult 
population and to modify these where possible.  This will help determine why 
vaccination rates are low. 
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Health impact assessments and quality improvement projects for future practice 
can keep cost, access, education, and surveillance in mind. Providers need to understand 
and educate regarding the importance of vaccination. This will help to decrease disease 
and ultimately aid in disease eradication in the future.  
 
Implications for Health Policy 
 There are often bills introduced to the House and Senate that relate back to 
vaccinations.  For example, there is currently a bill that was introduced to the House on 
November 13, 2019, this was called "Protecting Seniors Though Immunization Act of 
2019."  This bill is to amend the Social Security Act to specify that "certain deductible, 
coinsurance, initial coverage limit, and cost-sharing requirements that apply under the 
Medicare prescription drug benefit shall not apply to vaccines that are recommended by 
the Advisory Committee on Immunization Practices of the Centers for Disease Control 
and Prevention” (GovTrack, 2021). This includes the PPSV23 vaccination. These bills 
are necessary to help control vaccination access, pricing and ultimately improve 
vaccination rates.   
Implications for Education 
  A strong recommendation by a health care provider is the key reason that patients 
choose to vaccinate. Studies show that patients who receive a provider recommendation 
are 4-5 times more likely to receive a vaccination (CDC, 2019b). It is important for 
providers to be educated on how important their recommendation is for patients to hear. 
That way they can use a presumptive approach that assumes that the patient will 
vaccinate if being offered.  
  This recommendation will be enough for most patients; - however, there will be 
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some patients that will require more education and information prior to receiving the 
vaccine.  So, all healthcare members need education regarding vaccination schedules, 
side effects, and efficacies. Additionally, they need to be able to be available to provide 
patient with the needed resources for discussion of the benefits and risks of vaccination. 
Conclusion 
The aim of this scholarly project was to increase PPSV23 vaccination rates in 
adults age 65 years of age and older in a midwestern primary care clinic after provider 
and staff education were performed. Comparison of vaccination rates from April 1-May 
31, 2020, to the same days in 2021 showed a 10% vaccination rate increase after the 
intervention consisting of patient awareness of vaccination status, assessment of 
vaccination status at the time of appointment, use of standing orders, provider 
recommendation and use of EHR reminders.  
The outcome of the study enhanced the awareness of the PPSV23 vaccination to 
the providers and staff at the clinic in which the intervention was implemented. Even 
though the study’s results are optimistic regarding the increase of PPSV23 vaccination 
rates, recommendations for further research were addressed. In order to achieve an 
PPSV23 vaccination rate of at least 90%, providers must continue to educate patients on 
the cancer-preventing benefits the PPSV23 vaccination and make strong vaccination 
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Pneumococcal Vaccination Survey: 
We noticed today that you did not receive the pneumococcal vaccination. 
This survey is attempting to gather information on reasons why. This is for 
research purposes only and results will not be able to be placed back to you 
nor will they affect the treatment you receive at our office.  
 
Please check one or more of the boxes below:  
 
 Lack of provider recommendation/ was not discussed or aware 
 Lack of ability to pay or fear of cost 
 Religious Reason 
 Personal Belief 
 Safety Concerns (regarding side effects) 
 Fear (of needles) 
 Desire for additional information 
 Wanting to get the Covid vaccination and have to wait based on 
timing 
 Prefer not to disclose my reasoning 
 Other, please describe______________________________________ 
